Aktuelle Neurologie, Table of Contents Aktuelle Neurologie 2013; 40(01): 49-50DOI: 10.1055/s-0032-1332879 Kompetenznetz Multiple Sklerose © Georg Thieme Verlag KG Stuttgart · New York Aktuelles aus der Forschung T. Korn 1 Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, TU München , S. G. Meuth 2 Klinik und Poliklinik für Neurologie, Abteilung für Entzündliche Erkrankungen des Nervensystems und Neuroonkologie, Universitätsklinikum Münster › Author Affiliations Recommend Article Abstract Buy Article Full Text References Literatur 1 Schattling B, Steinbach K, Thies E et al. TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 2012; 18: 1805-1811 2 Rinaldi F, Seppi D, Calabrese M et al. Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings. Multiple Sclerosis Journal 2012; 18: 1640-1643 3 Jander S, Turowski B, Kieseier BC et al. Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod. Multiple Sclerosis Journal 2012; 18: 1650-1652 4 Lucchinetti CF, Gavrilova RH, Metz I et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 2008; 131: 1759-1775 5 Chen Y, Bord E, Tompkins T et al. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med 2009; 361: 1067-1074 6 Jilek S, Jaquiéry E, Hirsch HH et al. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. Lancet Neurol 2010; 9: 264-272 7 Jelcic I, Aly L, Binder TMC et al. T Cell Epitope Mapping of JC Polyoma Virus-Encoded Proteome Reveals Reduced T Cell Responses in HLA-DRB1*04:01+ Donors. J Virol 2013; (Jan 9, E-pub ahead of print) 8 Perkins MR, Ryschkewitsch C, Liebner JC et al. Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy. PLoS Pathog 2012; 8: e1003014 9 Saidha S, Sotirchos ES, Ibrahim MA et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 2012; 11: 963-972 10 Srivastava R, Aslam M, Kalluri SR et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012; 367: 115-123
